K170670

Substantially Equivalent

Etest Ceftolozane/ Tazobactam (0.016-256 ug/ml)

Applicant: bioMerieux, Inc.
Product code: JWY
Advisory panel: Microbiology
Date received: 2017-03-06
Decision date: 2017-05-31
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Hazelwood, MO, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.